Disruption of the Sp1-BCR/ABL axis by Sp1 siRNA, miR-29b and BORT impaired BCR/ABL kinase signaling leading to the blockage of CML cell proliferation. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.